As part of the rollout of our global infrastructure, we’re excited to share that Enzyme.Blue is now live on Base — enabling businesses and institutions to create and manage tokenized strategies on Base, and opening the door to new on-chain possibilities.

Enzyme.Blue — The All-Around Platform

At the heart of Enzyme’s infrastructure is our Vault-as-a-Service offering — and central to that is Enzyme.Blue, our newly rebranded, institutional-grade digital asset management platform. Enzyme.Blue is a comprehensive solution that empowers businesses and institutions to launch and manage tokenized financial products — including regulated tokenized funds, on-chain investment pools, and structured products — with full control, flexibility, and seamless integration into the on-chain ecosystem.

Launch Tokenized Strategies on Base

By leveraging Enzyme Vaults as programmable investment vehicles, staking providers, asset managers, institutions, decentralized apps, and DAOs can now tap into the Base ecosystem to build and manage their on-chain strategies — faster and more efficiently.

Deploying an Enzyme Vault takes just seconds. Teams can create a Vault on Base using our integrated apps, with access to key protocols like Morpho, Aave, and 1inch — all from a single interface designed for speed and simplicity.

To support builders across the Base ecosystem, we’ll continue integrating Base-native protocols into Enzyme.Blue, ensuring teams have the tools they need to execute strategies with efficiency and freedom. We’re already supporting a growing number of projects building tokenized strategies on Base — and we’re just getting started.

Interested in building on Base using Enzyme.Blue? Let's get in touch.

Igniting the future of finance

By lowering the barriers to building tokenized products, Enzyme.Blue supports Base’s mission to bring the world on-chain — making it easier for developers and institutions to unlock tokenized innovation and bring new use cases to life.